Jane Street Group, LLC Zynerba Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$2.88 - $4.3 $72,288 - $107,930	-25,100 Reduced 31.37%	54,900 $158,000
Q3 2021 Nov 16, 2021	BUY	$3.72 - $5.35 $131,688 - $189,390	35,400 Added 79.37%	80,000 $339,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $5.98 $218,310 - $340,860	-57,000 Reduced 56.1%	44,600 $236,000
Q1 2021 May 18, 2021	BUY	$3.33 - $8.76 $338,328 - $890,016	101,600 New	101,600 $472,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.